Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac

A novel therapeutic vaccine for chronic hepatitis B (CHB) treatment comprising the recombinant hepatitis B surface (HBsAg) and nucleocapsid (HBcAg) antigens has been developed. Preclinical and clinical trials (CT) evidenced safety and immunogenicity in animal models as well as in phases I, II, and I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Euroasian J Hepatogastroenterol
Main Authors: Fernández, Guillermo, L Sanchez, Ana, Jerez, Everardo, E Anillo, Luis, Freyre, Freya, A Aguiar, Jorge, Leon, Yamila, Cinza, Zurina, A Diaz, Pablo, Figueroa, Nelvis, Muzio, Verena, G Nieto, Gerardo, Lobaina, Yadira, Aguilar, Arístides, Penton, Eduardo, C Aguilar, Julio
Formato: Artigo
Idioma:Inglês
Publicado em: Jaypee Brothers Medical Publishers 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6395482/
https://ncbi.nlm.nih.gov/pubmed/30828555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10018-1279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados